ArticleNano-micro letters2026
Efficient and Pure I-III-VI AIGS Quantum Dot-Based Light-Emitting Diodes via Ligand-Reshaped Surface State.
Article in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The I-III-VI silver indium gallium sulfide (AIGS) quantum dots (QDs) have gained extensive attention owing to their tunable emission wavelength and ecofriendly composition; however, the performance of AIGS QD-based light-emitting diodes (QLEDs) remains constrained by suboptimal surface state, significantly lagging behind that of other heavy-metal-containing QD counterparts. Herein, we propose a ligand-reshaped strategy aimed at optimizing the surface state of AIGS QDs to enhance the performance of QLEDs. A polyfunctional ligand, dimercaptosuccinic acid (DSA), is introduced to reshape the QD surface through passivation of uncoordinated Ga
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.